📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions (2024)

First Author: Marshall AD

Attributed to: The MRC Addiction Research Clinical Training programme: MARC funded by MRC

Abstract

No abstract provided

Bibliographic Information

Type: Journal Article/Review

Volume: 9

Parent Publication: Lancet Gastroenterol Hepatol

Issue: 4